Analysis of murine and human Treg subsets in inflammatory bowel disease

Sun,Xiaoyun; He,Shaoheng; Lv,Changlong; Sun,Xun; Wang,Junling; Zheng,Wenjiao; Wang,Danan

doi:10.3892/mmr.2017.6912

Analysis of murine and human Treg subsets in inflammatory bowel disease

Authors:
- Xiaoyun Sun
- Shaoheng He
- Changlong Lv
- Xun Sun
- Junling Wang
- Wenjiao Zheng
- Danan Wang
View Affiliations

Affiliations: Department of Immunology, School of Basic Medical Science, China Medical University, Shenyang, Liaoning 110001, P.R. China, Allergy and Clinical Immunology Research Centre, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121001, P.R. China
Published online on: July 4, 2017 https://doi.org/10.3892/mmr.2017.6912
Pages: 2893-2898

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previous studies have indicated that regulatory T cells serve essential roles in maintaining intestinal homeostasis, however, the role of different Treg subsets in modulating inflammatory bowel disease has still not been addressed clearly. In the present study, the authors measured the percentage of Foxp3+ IL‑10+ TGF‑β+ natural Tregs, Foxp3‑ IL‑10+ TGF‑β‑ induced Tregs, CD127‑ induced Tregs and CD8+ Tregs at different time points in DSS‑induced experimental colitis model in murine lamina propria lymphocytes, mesenteric lymph node and peripheral blood. In addition, the authors compared the frequency of four Treg subsets in patients diagnosed of ulcerative colitis at different stages with enrolled healthy controls. The percentage of Foxp3+ IL‑10+ TGF‑β+ natural Tregs decreased in acute stage of both human and mice was observed, but proliferated significantly during remittent stage. Foxp3‑ IL‑10+ TGF‑β‑ inducible (i) Treg and CD127‑ iTreg was observed as being significantly decreased percentage in LPL at 4 and 7 days, the frequency of Foxp3‑ IL‑10+ TGF‑β‑ iTreg cells became decreased and CD127‑ iTreg only slightly increased at the chronic stage following DSS induction. However, the proportion of both Foxp3‑ IL‑10+ TGF‑β‑ iTreg and CD127‑ iTreg was nearly unchanged in human IBD. Although intestinal inflammation decreased the percentage of CD8+ Tregs, it remained lower in the remittent stage of human IBD. Only enhanced proliferation of lamina propria lymphocytes‑derived CD8+ Treg was reported at 7 days in dextran sodium sulfate‑induced murine colitis. The results demonstrated that Foxp3+ IL‑10+ TGF‑β+ natural Tregs may serve an essential role in exhibiting suppressive and protecting from immune‑related mucosal injury during chronic stage in inflammatory bowel disease.

View Figures

View References

1	Dixon LJ, Kabi A, Nickerson KP and McDonald C: Combinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis. Inflamm Bowel Dis. 21:912–922. 2015. View Article : Google Scholar : PubMed/NCBI
2	Giusti S, Tani U and Neri E: Inflammatory bowel diseasesCT Colonography Atlas. Springer; pp. 75–83. 2013, View Article : Google Scholar
3	Baumgart DC and Sandborn WJ: Inflammatory bowel disease: Clinical aspects and established and evolving therapies. Lancet. 369:1641–1657. 2007. View Article : Google Scholar : PubMed/NCBI
4	Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, et al: Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 491:119–124. 2012. View Article : Google Scholar : PubMed/NCBI
5	Knights D, Lassen KG and Xavier RJ: Advances in inflammatory bowel disease pathogenesis: Linking host genetics and the microbiome. Gut. 62:1505–1510. 2013. View Article : Google Scholar : PubMed/NCBI
6	Round JL and Mazmanian SK: The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 9:313–323. 2009. View Article : Google Scholar : PubMed/NCBI
7	Li L, Shi QG, Lin F, Liang YG, Sun LJ, Mu JS, Wang YG, Su HB, Xu B, Ji CC, et al: Cytokine IL-6 is required in Citrobacter rodentium infection-induced intestinal Th17 responses and promotes IL-22 expression in inflammatory bowel disease. Mol Med Rep. 9:831–836. 2014.PubMed/NCBI
8	Troncone E, Marafini I, Pallone F and Monteleone G: Th17 cytokines in inflammatory bowel diseases: Discerning the good from the bad. Int Rev Immunol. 32:526–533. 2013. View Article : Google Scholar : PubMed/NCBI
9	Jiang WY, Zhang XF and Zhang HJ: Elevated levels of Th17 cells and Th17-related cytokines in patients with inflammatory bowel disease. J Gastroenterol Hepatol. 28:368. 2013.
10	Lim SM, Jeong JJ, Choi HS, Chang HB and Kim DH: Mangiferin corrects the imbalance of Th17/Treg cells in mice with TNBS-induced colitis. Int Immunopharmacol. 34:220–228. 2016. View Article : Google Scholar : PubMed/NCBI
11	Omenetti S and Pizarro TT: The Treg/Th17 Axis: A dynamic balance regulated by the gut microbiome. Front Immunol. 6:6392015. View Article : Google Scholar : PubMed/NCBI
12	Fantini MC, Rizzo A, Fina D, Caruso R, Becker C, Neurath MF, Macdonald TT, Pallone F and Monteleone G: IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells. Eur J Immunol. 37:3155–3163. 2007. View Article : Google Scholar : PubMed/NCBI
13	Yamada A, Arakaki R, Saito M, Tsunematsu T, Kudo Y and Ishimaru N: Role of regulatory T cell in the pathogenesis of inflammatory bowel disease. World J Gastroenterol. 22:2195–2205. 2016.PubMed/NCBI
14	Chen Y, Sun R, Wu X, Cheng M, Wei H and Tian Z: CD4+CD25+Regulatory T cells inhibit natural killer cell hepatocytotoxicity of hepatitis B virus transgenic mice via membrane-bound TGF-β and OX40. J Innate Immun. 8:30–42. 2016. View Article : Google Scholar : PubMed/NCBI
15	Langenhorst D, Gogishvili T, Geyer B and Hunig T: Regulation of IL-10 production in ‘natural’ regulatory T cells. Wien Klin Wochen. 120:170. 2008.
16	Lord JD, Shows DM, Chen J and Thirlby RC: Human blood and mucosal regulatory T cells express activation markers and inhibitory receptors in inflammatory bowel disease. PLoS One. 10:e01364852015. View Article : Google Scholar : PubMed/NCBI
17	Verhagen J and Wraith DC: Antigen-specific iTreg cells require both IL-10 and CTLA-4 to control autoimmune disease. Immunology. 140:140. 2013.
18	Singh A, Seavey C, Horvath K and Mohiuddin M: Induced T regulatory (iTreg) cells suppress T and B cell immune responses. Xenotransplantation. 18:271–272. 2011.
19	Haribhai D, Chatila TA and Williams CB: Immunotherapy with iTreg and nTreg cells in a murine model of inflammatory bowel disease. Methods Mol Biol. 1422:197–211. 2016. View Article : Google Scholar : PubMed/NCBI
20	Schmitt EG, Haribhai D, Williams JB, Aggarwal P, Jia S, Charbonnier LM, Yan K, Lorier R, Turner A, Ziegelbauer J, et al: IL-10 produced by induced regulatory T cells (iTregs) controls colitis and pathogenic Ex-iTregs during immunotherapy. J Immunol. 189:5638–5648. 2012. View Article : Google Scholar : PubMed/NCBI
21	Rifa'i M, Kawamoto Y, Nakashima I and Suzuki H: Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med. 200:1123–1134. 2004. View Article : Google Scholar : PubMed/NCBI
22	Jebbawi F, Fayyad-Kazan H, Merimi M, Lewalle P, Verougstraete JC, Leo O, Romero P, Burny A, Badran B, Martiat P and Rouas R: A microRNA profile of human CD8(+) regulatory T cells and characterization of the effects of microRNAs on Treg cell-associated genes. J Transl Med. 12:2182014. View Article : Google Scholar : PubMed/NCBI
23	Ménager-Marcq I, Pomié C, Romagnoli P and van Meerwijk JP: CD8+CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice. Gastroenterology. 131:1775–1785. 2006. View Article : Google Scholar : PubMed/NCBI